Scout | U.S. Food and Drug Administration (FDA) Developing Novel Technologies for Identification/Characterization of Glycans on Glycoproteins

grant

U.S. Food and Drug Administration (FDA) Developing Novel Technologies for Identification/Characterization of Glycans on Glycoproteins

FDA Office and Location: A research opportunity is available within the Food and Drug Administration (FDA) in The Center for Drug Evaluation and Research (CDER), The Office of Pharmaceutical Quality Research (OPQR), Office of Pharmaceutical Quality (OPQ), located at Silver Spring, Maryland.

The Center for Drug Evaluation and Research (CDER) performs an essential public …

Source

Agency: U.S. Food and Drug Administration

Dates

Application Deadline: September 30, 2026

Eligibility

industry:education

industry:energy

industry:manufacturing

industry:research

location:maryland

Supporting Links

Documents

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers